Ikarian Capital’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-431,100
Closed -$1.67M 172
2024
Q4
$1.67M Buy
431,100
+378,100
+713% +$3.01M 0.23% 87
2024
Q3
$535K Buy
+53,000
New +$344K 0.07% 116
2024
Q2
Sell
-103,000
Closed -$1.54M 124
2024
Q1
$1.54M Sell
103,000
-397,000
-79% -$6.54M 0.17% 95
2023
Q4
$7.26M Buy
+500,000
New +$6.08M 0.68% 50
2023
Q3
Sell
-286,700
Closed -$6.29M 155
2023
Q2
$6.29M Buy
286,700
+246,700
+617% +$7.72M 1% 31
2023
Q1
$1.24M Buy
+40,000
New +$497K 0.28% 67

Other funds holding BMEA

Ikarian Capital's BMEA Position: Q3 2023 in Review

Ikarian Capital sold out of Biomea Fusion (BMEA) in Q3 2023, closing a stake of 275,875 shares — an estimated $6.06M sold.

Ikarian Capital first reported a position in BMEA in Q1 2023 and held it in 2 quarters. The position peaked at $6.54M in Q1 2023. 85 funds tracked by Wall St. Rank hold BMEA as of Q3 2023.

  • Ikarian Capital reported no remaining Biomea Fusion position as of Q3 2023 after selling out during the quarter.
  • Ikarian Capital sold 275,875 Biomea Fusion shares in Q3 2023, an estimated $6.06M.
  • Ikarian Capital first reported a position in Biomea Fusion in Q1 2023 and held it in 2 quarters.
  • Ikarian Capital's Biomea Fusion position peaked at $6.54M in Q1 2023.
  • 85 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2023.

Based on Ikarian Capital's 13F filing for Q3 2023, filed 14 Nov 2023.